Sol Barer Archives - CDR – Chain Drug Review

Teva names Kåre Schultz as new CEO

September 11, 2017 by Chain Drug Review Erez Vigodman, Kåre Schultz, Sol Barer, Teva Pharmaceutical Industries, Yitzhak Peterburg Business, Leading Headlines, Pharmacy, Supplier News

JERUSALEM, Israel — Kåre Schultz is joining Teva Pharmaceutical Industries Ltd. as president and chief executive officer. Teva said Monday that Schultz will take the reins from interim CEO Yitzhak Peterburg, who took on that role when Erez Vigodman stepped down as president and chief executive earlier this year. Peterburg had been Teva’s chairman but

Teva CEO Erez Vigodman steps down

February 7, 2017 by Chain Drug Review Erez Vigodman, Sol Barer, Teva Pharmaceutical Industries, Yitzhak Peterburg Business, Leading Headlines, Pharmacy, Supplier News

JERUSALEM, Israel — Erez Vigodman is stepping down as president and chief executive officer of Teva Pharmaceutical Industries Ltd. Teva said late Monday that it has appointed chairman Yitzhak Peterburg as interim president and CEO, effective immediately. In addition, Teva’s board of directors has elected Sol Barer, a board member since January 2015, as chairman.